Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Drugs Audit is a digital audit and compliance platform operated by DRUGS AUDIT LTD. Founded in 2021, it originated from a prototype project developed in collaboration with a group of NHS Trusts. Its positioning is not simply as a self-service form tool, but as a “software platform + fully managed service”: customers provide the audit direction and specifications, while the team helps design, build, and deliver the audit workflow.
The platform provides web-based online audit data collection, suitable for gathering information from different locations within an organization. Its customized audit builder supports complex audit designs. Audit data is turned into interactive dashboards and formatted reports via Microsoft Power BI, helping users understand the status of different Trusts or organizations during the audit period. The site also emphasizes compliance and risk monitoring, as well as driving corrective actions and continuous improvement after audits are completed.
The website does not publicly disclose plans, seat-based pricing, project-based pricing, organization-level pricing, or payment methods. It only offers a “Book a free consultation” option, indicating a more consultative sales model with customized quotes. For buyers who need to assess budgets in advance, this lack of transparency is a drawback.
The main advantages are its high level of managed service, which can reduce the burden on healthcare teams to build audit workflows themselves; Power BI analytics are management-reporting friendly; and its experience working with NHS Trusts gives it a strong fit for healthcare audit scenarios. The drawbacks are limited disclosure of technical details: there is no visible information on APIs, SSO, granular permissions, audit logs, data residency, compliance certifications, or other common enterprise software requirements. Third-party integrations are also only explicitly mentioned in relation to Microsoft/Power BI.
It is better suited to NHS Trusts, hospital groups, pharmaceutical or clinical process teams, and organizations that want to digitize audits quickly and improve compliance visibility without fully building their own system. If an organization requires open APIs, self-hosting, complex permission models, or clearly stated compliance certifications, it should confirm these details with the vendor.
The website does not provide information about access from mainland China, deployment nodes, or localization. Actual availability is unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on drugsaudit.com official site.
drugsaudit.com is an United Kingdom Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach drugsaudit.com directly.